Molecular Milestones and Survival Outcomes of Ponatinib Treatment in Patients With Chronic Myeloid Leukemia and Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia: A Real-World Analysis

Tseng T.C.Chang, Yu-SungYu-SungChangTsai, Xavier Cheng-HongXavier Cheng-HongTsaiLin, Ming-EnMing-EnLinTien, Feng-MingFeng-MingTienHuang, Huai-HsuanHuai-HsuanHuangYUN-CHU LINJIA-HAU LIULiu, Ming-ChihMing-ChihLiuLin, Chien-ChinChien-ChinLinCheng, Chieh-LungChieh-LungChengHsu, Szu-ChunSzu-ChunHsuYao, MingMingYaoTseng, Mei-HsuanMei-HsuanTsengPeng, Yen-LingYen-LingPengKo, Bor-ShengBor-ShengKoYang, Yung-LiYung-LiYangSHIANN-TANG JOUHou, Hsin-AnHsin-AnHouChou, Wen-ChienWen-ChienChou2026-03-272026-03-272026-01-0121522650https://scholars.lib.ntu.edu.tw/handle/123456789/736865falseMolecular Milestones and Survival Outcomes of Ponatinib Treatment in Patients With Chronic Myeloid Leukemia and Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia: A Real-World Analysisjournal article2-s2.0-105017554077